 Research on the effects of treatments often overlooks the shared interests of patients and clinicians.As a result, questions they both consider important are not addressed.The pharmaceutical and medical technology industries and academia play essential roles in developing new treatments, but their priorities are not necessarily the same as those of patients and clinicians.